<?xml version="1.0" encoding="utf-8"?>
<Journal>
<Journal-Info>
<name>International Journal of Pharma and Bio Sciences</name>
<website>ijpbs.net</website>
<email>editorijpbs@rediffmail.com (or) editorofijpbs@yahoo.com (or) prasmol@rediffmail.com</email>
</Journal-Info>
<article>
<article-id pub-id-type='other'>10.22376/ijpbs.2019.10.1.p1-12</article-id>
<issue_number>Volume 5 Issue 4</issue_number>
<issue_period>2014 (October - December)</issue_period>
<title>ADVANCED LIPID PROFILE TESTING IN CARDIO VASCULAR RISK ASSESSMENT – A REVIEW </title>
<abstract>Advanced Lipid Profile testing is a combination of laboratory investigations which provides a more direct and detailed lipid subfraction measurements. Some studies have claimed that this additional information on lipids could improve the ability to predict the risk assessment of cardiovascular disease from 40% (existing biochemical investigations) to more than 90% (advanced lipid profile testing). Some of these tests include LDL phenotyping, Vertical auto profile test, Nuclear magnetic resonance test, Lipoprotein(a), Lipoprotein-associated phospholipase A2. These additional biomarkers may offer a way to further evaluate the residual risk and could become secondary treatment targets to further lower risk.</abstract>
<authors>DR.MANJULA DEVI.A.  AND  DR.RATHI ROOPAVATHY. J</authors>
<keywords>LDL phenotyping , VAP, NMR, GGE,  Lp-PLA2.</keywords>
<pages>745-748</pages>
</article>
</Journal>
